958635-19-3Relevant articles and documents
ANTAGONIST COMPOUNDS
-
Paragraph 00412, (2022/02/09)
The present invention relates to compounds of formula (I) shown below: wherein R1, R2, R3, R4, R5 and R6 are each as defined in the application. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or conditions in which adenosine A2a and/or A2b receptor activity is implicated, such as, for example, cancer.
PYRAZOLOPYRIDINE KINASE INHIBITORS
-
, (2011/08/21)
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, co
A practical synthesis of differentially protected 2-(Hydroxymethyl) piperazines
Gao, Hongwu,Renslo, Adam R.
, p. 8591 - 8592 (2008/02/13)
(Chemical Equation Presented) An efficient and scalable synthesis of three differentially protected 2-(hydroxymefhyl)piperazines is presented, starting from optically active and commercially available (2S)-piperazine-2-carboxylic acid dihydrochloride. These synthetic building blocks are useful in the preparation of biologically active compounds and as chemical scaffolds for the construction of combinatorial libraries.